Home - Products - Others - Other Targets - VIP (1 - 12), human, porcine, rat

VIP (1 - 12), human, porcine, rat

CAS No. 120928-03-2

VIP (1 - 12), human, porcine, rat( ——— )

Catalog No. M41759 CAS No. 120928-03-2

VIP (1-12), human, porcine, rat, ovine is a vasoactive intestinal peptide (VIP) fragment. VIP (1-12), human, porcine, rat, ovine is a ligand for the CD4 (T4)/human immunodeficiency virus receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    VIP (1 - 12), human, porcine, rat
  • Note
    Research use only, not for human use.
  • Brief Description
    VIP (1-12), human, porcine, rat, ovine is a vasoactive intestinal peptide (VIP) fragment. VIP (1-12), human, porcine, rat, ovine is a ligand for the CD4 (T4)/human immunodeficiency virus receptor.
  • Description
    VIP (1-12), human, porcine, rat, ovine is a vasoactive intestinal peptide (VIP) fragment. VIP (1-12), human, porcine, rat, ovine is a ligand for the CD4 (T4)/human immunodeficiency virus receptor.
  • In Vitro
    ———
  • In Vivo
    Animal Model:Male Wistar rats (250 g) Dosage:1, 2.5, 5, 10 μg Administration:Intracerebroventrical injection Result:Caused a dose-dependent decrease in the response.
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    120928-03-2
  • Formula Weight
    1425.49
  • Molecular Formula
    C61H88N18O22
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Takashima A, et, al. Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat. Peptides. 1993 Oct;14(5):1067-71.
molnova catalog
related products
  • Inebilizumab

    Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells.

  • Niraparib Tosylate M...

    Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.

  • urolithin M6

    urolithin M6 (UM6) is an ellagitannin metabolite produced by gut microbiota, was identified as a putative galloflavin mimetic